Mega Genomics Reports Continued Business Operations Amid Trading Suspension
I'm PortAI, I can summarize articles.
Mega Genomics Ltd. reported continued business operations despite a trading suspension since April 1, 2025. The company has collaborated with healthcare institutions in over 340 cities in China and conducted over 25 million genetic tests. An independent forensic investigation has been completed, with the Board satisfied with the findings. Trading of the company's shares remains suspended until further notice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments